"10.1371_journal.pone.0147006","plos one","2016-01-22T00:00:00Z","Henry L Fu; Jenna L Mueller; Melodi J Whitley; Diana M Cardona; Rebecca M Willett; David G Kirsch; J Quincy Brown; Nimmi Ramanujam","Department of Biomedical Engineering, Duke University, Durham, North Carolina, United States of America; Department of Pharmacology & Cancer Biology, Duke University School of Medicine, Durham, North Carolina, United States of America; Department of Pathology, Duke University School of Medicine, Durham, North Carolina, United States of America; Department of Electrical and Computer Engineering, University of Wisconsinâ€”Madison, Madison, Wisconsin, United States of America; Department of Radiation Oncology, Duke University School of Medicine, Durham, North Carolina, United States of America; Department of Biomedical Engineering, Tulane University, New Orleans, Louisiana, United States of America","Conceived and designed the experiments: HF JM MW DK JB NR. Performed the experiments: HF JM MW. Analyzed the data: HF JM DC RW. Contributed reagents/materials/analysis tools: MW DK RW. Wrote the paper: HF.","Dr. Ramanujam has founded a company called Zenalux Biomedical and she and other team members have developed technologies related to this work where the investigators or Duke University may benefit financially if this system is sold commercially. Dr. Kirsch consults for and owns stock in Lumicell Diagnoistics, which is a company commercializing intraoperative imaging systems. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The other authors declare no competing financial interests.","2016","01","Henry L Fu","HLF",8,TRUE,6,3,4,1,TRUE,TRUE,FALSE,0,NA,FALSE
